Consumption of Cross-Linked Resistant Starch (RS4XL) on Glucose and Insulin Responses in Humans by Al-Tamimi, Enas K. et al.
Hindawi Publishing Corporation
Journal of Nutrition and Metabolism
Volume 2010, Article ID 651063, 6 pages
doi:10.1155/2010/651063
Clinical Study
ConsumptionofCross-Linked ResistantStarch (RS4XL)o n
Glucoseand InsulinResponses in Humans
EnasK.Al-Tamimi,1 PaulA.Seib,2 Brian S. Snyder,1 andMarkD.Haub1
1Department of Human Nutrition, Kansas State University, Manhattan, KS 66506, USA
2Department of Grain Science and Industry, Kansas State University, Manhattan, KS 66506, USA
Correspondence should be addressed to Mark D. Haub, haub@ksu.edu
Received 19 May 2009; Revised 26 June 2009; Accepted 9 July 2009
Academic Editor: Michael Pagliassotti
Objective. The objective was to compare the postprandial glycemic and insulinemic responses to nutrition bars containing either
cross-linked RS type 4 (RS4XL) or standard wheat starch in normoglycemic adults (n = 13; age = 27±5 years; BMI = 25±3kg/m 2).
Methods. Volunteers completed three trials during which they consumed a glucose beverage (GLU), a puﬀed wheat control bar
(PWB), and a bar containing cross-linked RS4 (RS4XL) matched for available carbohydrate content. Serial blood samples were
collectedovertwohoursandglucoseandinsulinconcentrationsweredeterminedandtheincrementalareaunderthecurve(iAUC)
was calculated. Results. The RS4XL peak glucose and insulin concentrations were lower than the GLU and PWB (P<. 05). The
iAUC for glucose and insulin were lower following ingestion of RS4 compared with the GLU and PWB trials. Conclusions.T h e s e
data illustrate, for the ﬁrst time, that directly substituting standard starch with RS4XL, while matched for available carbohydrates,
attenuated postprandial glucose and insulin levels in humans. It remains to be determined whether this response was due to the
dietary ﬁber and/or resistant starch aspects of the RS4XL bar.
Copyright © 2010 Enas K. Al-Tamimi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Consumption of whole grains has been recommended to
improve insulin sensitivity and lower serum glucose and
insulin concentrations. Whole grain consumption of three
servings or more per day was among changes that were
included in the 2005 dietary guidelines to reduce the risk
of acquiring chronic diseases [1]. Whole grains are major
sources of dietary ﬁber (DF), yet typical DF consumption
patterns do not meet the recommended 25–35g per day.
Therefore, eating more grain-based ﬁber-rich foods is war-
ranted to help optimize health and potentially manage some
chronic metabolic conditions.
At present, resistant starches (RSs) have drawn broad
interest for their health beneﬁts and functional properties
[2, 3]. Initial clinical studies demonstrated that RS has prop-
erties similar to soluble ﬁber, shows promising physiological
beneﬁts in humans, and may prevent disease. Several poten-
tial physiological beneﬁts ascribed to RS include attenuation
of blood glucose and insulin levels in both healthy and
diabetic individuals, positive eﬀects on large bowel health
and prevention of colonic cancer, increased absorption of
minerals, serving as a prebiotic, and increased fat oxidation
[3–9]. There are four basic “types” of RS. Type 1 (RS1)
is composed of starch granules embedded in indigestible
plant material. Type 2 (RS2) is native granular starch with
a B-type x-ray pattern, such as found in potato and high-
amylose maize. Type 3 (RS3) is crystallized starch and
maltodextrins made by alternate cooking/cooling processes
on starchy materials. Type 4 (RS4) is chemically modiﬁed
starch typically through esteriﬁcation, crosslinking (RS4XL),
or transglycosylation.
The majority of human clinical trials have been con-
ducted using only RS2 or RS3, which tend to illustrate
decreased blood glucose following consumption of foods
with these starches added [3, 6, 10–15]. It is diﬃcult to
fully understand the beneﬁcial capacity of RS due to the
methods used in the human clinical trials that tested the
eﬃcacy of RS. For example, one clinical trial failed to control
both the amount and source of all the ingredients [16].2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
In a study investigating the eﬀects of esteriﬁed RS type 4
(RS4OSA),Heacocketal.[17]reportedthatRS4OSA decreased
peak glucose and insulin levels when it was administered
in water, but RS is typically consumed in foods. Also, in
studies by Behall et al. [18, 19], the amount of available
carbohydratediﬀered,whichlimitsthecapacitytodetermine
if the attenuation of glucose and insulin was due to the RS or
the fact there was less available carbohydrate. Furthermore,
Robertson et al. [6] provided packets containing RS2 for
volunteers to sprinkle on their food thereby not illustrating
the eﬀects that might be achieved when provided in the
food supply. Taken together, the available data illustrate
that RS has the potential to lower blood glucose. However,
few clinical trials testing the eﬀects of RS have controlled
ingredients and the amount of available carbohydrates to
better delineate the role of RS in aﬀecting the insulin
and glucose responses, and no published clinical trials
investigating the glucose lowering potential of RS4XL exist.
Therefore, the aim of this study was to investigate
the acute eﬀects of consuming RS4XL incorporated into a
nutrition bar, while controlling for nonstarch ingredients
and available carbohydrates, on postprandial glucose and
insulin responses in young adults with a randomized clinical
trial (NCT00687960, clinicaltrials.gov).
2.MaterialsandMethods
2.1. Subjects. The Institutional Review Board of Kansas State
Universityapprovedthestudy,andwritteninformedconsent
wasobtained from allvolunteers prior of the study. Inclusion
criteria were no diagnosis of acute or chronic metabolic
diseases, free of gastrointestinal disorders, body mass index
of 23–30kg/m2, and nonsmokers. Volunteers were screened
for glucose tolerance using a two hour 75g glucose tolerance
test prior to participation. Eighteen healthy younger adults
were recruited and 13 participated in and completed the
study, while the other ﬁve did not meet the criteria. Of
the 13 volunteers (age = 27±5y e a r s ,B M I= 25±3kg/m 2,
HOMA = 0.94±0.34), 7 were females and 6 were males.
Based on BMI values, these volunteers all have similar risks
for all-cause and obesity-related mortality [20]. Also, an oral
glucose tolerance test was performed prior to enrollment to
ensure each volunteer had normal glucose tolerance.
2.2. Oral Glucose Tolerance Test. Prior to enrollment, volun-
teers arrived after a 12 hours overnight fast. Blood samples
were drawn by ﬁnger stick at baseline and 120 minutes
after ingesting 75g of glucose in solution (296 mL; Sun-
Dex 75g, Fisher Scientiﬁc, Houston, Tex, USA). Samples
were analyzed in duplicate for glucose concentration (YSI
2300 STAT, Yellow Springs, Ohio, USA). The oral glucose
tolerance test was used to conﬁrm the absence of prediabetes
or diabetes.
2.3. Study Design. A l lt r i a l sw e r ep e r f o r m e da tt h eH u m a n
Metabolism Laboratory at Kansas State University. Volun-
teers completed three trials via a controlled randomized
crossover design. During each trial, volunteers consumed
Table 1: Ingredients and their concentrations by relative weight (%
total) in the test bars.
PWB RS4XL
Puﬀed Wheata 34 —
Resistant Starch type 4b —3 4
Corn Syrupc 20 20
Wheat Germd 18 18
Brown Sugare 11 11
Waterf 10 10
Gum Acaciag 66
Panodan 150K
h 11
a Quaker Oats
b Fibersym RW; MGP Ingredients, Inc.
c Karo light corn syrup
d Kretschmer Original Toasted
e C&H Pure Cane Sugar, golden brown
f Tap water (Manhattan, Kan)
g TIC Gums
h Danisco
one of the following: dextrose solution (198mL of a standard
75g oral glucose tolerance beverage; GLU), a control bar
containing puﬀed wheat (65g; PWB), and a bar containing
cross-linked RS4XL bar (80g; RS4XL)( Table 1). All treat-
ments were designed to provide 50g of available carbohy-
drate (Table 2) .A l lt r i a l sw e r ec o m p l e t e db ye a c hv o l u n t e e r
with at least a seven-day washout between testing days. This
was a quasiblinded experiment in that one treatment was a
beverage and the other two were in bar form, which were
randomly administered using a Latin Square design. Some
female volunteers did not use oral contraceptives, but others
used either contraceptive pills or progesterone injections.
Regardless, the females were scheduled to perform all the
trials during the follicular phase of their menstrual cycle and
each served as their own control.
2.4.ExperimentalBars. Theonlyalteredingredientsbetween
bars were either puﬀed wheat or RS4XL (Table 1). Brieﬂy,
the nutrition bars were prepared by adding puﬀed wheat
or cross-linked RS4 to wheat germ. The dose of the RS4XL
(27.2g) was intended to be close to the dose used previously
[6], whereby a signiﬁcant improvement in insulin sensitivity
was observed. The remaining ingredients (water, corn syrup,
brown sugar, gum acacia, and Panodan 150K) were heated
to 85
◦C over 4minutes, poured over the dry ingredients,
and then manually mixed quickly until dry ingredients were
evenly distributed throughout the mixture. The mixture was
scooped into a metal pan, pressed evenly throughout the
pan, and allowed to cool for 20minutes before cutting into
bars. Crude nutrient analysis was determined by proximate
analysis, while total dietary ﬁber was assessed independently
(Medallion Labs, Minneapolis, Minn) (Table 2). Available
carbohydrate was calculated as the diﬀerence between total
carbohydrate and dietary ﬁber as used previously [9].
Controlling for available carbohydrate in this fashion has
beenshowntoaﬀecttheglycemicresponse,whilecontrolling
for RS content does not necessarily aﬀect the glycemic
response [21].J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 2: Nutrient composition of each treatment per dose (GLU =
198mL; PWB = 65g; RS4 = 80g).
GLU
a PWB
b RS4b
XL Δe
Total Energy (kcal) 200 261 326 (65kcal, 125%)
Carbohydrate (g)
Total 50 56 71 (15 g, 127%)
Availablec 50 51 51 (0 g, 0%)
Total Dietary Fiber (g)
d — 5 20 (15g, 400%)
Fat (g) — 1 2 (1g, 200%)
Protein (g) — 7 6 (1g, 86%)
a glucose tolerance test beverage (Sun-Dex, Fisher Scientiﬁc, Houston, Tex)
b Crude nutrient composition was determined by proximate analysis (total
energy, total fat, total protein, total carbohydrate).
c derived by subtracting total dietary ﬁber from total carbohydrate.
d dietary ﬁber analysis was performed by Medallion Laboratory (Minneapo-
lis, Minn).
e diﬀerence (subtraction value, % value) between bars.
2.5. Food Tolerance Test. The postprandial test (two-hours
with seven blood samples) was modiﬁed from Flammang
et al. [22]. During each test, volunteers arrived to the
laboratory after a 10–12 hour overnight fast. An indwelling
catheter (Terumo, 22gx1, Terumo Medical Corporation,
Elekton, Md) was inserted into a forearm vein. The line
was kept patent with 0.9% isotonic saline solution (0.9%
sodium chloride USP, B. Braun Medical Inc., Irvine, Calif).
Ten minutes after inserting the IV catheter, the fasting blood
sample was collected. Thereafter, the volunteers consumed
the assigned food item for that day. The solution (GLU) or
bar was consumed within 10minutes. The treatment bars
were served with 198mL of water (to match the ﬂuid that
was consumed during the GLU trial). Relative to taking the
ﬁrstbiteoffood,bloodsampleswerecollectedat −10,10,20,
30, 60, 90, and 120minutes.
2.6. Blood Samples. After collection, blood samples were
centrifuged at 2,500rpm for 15 minutes at 4◦C. The plasma
was extracted from the vacutainer and immediately analyzed
in duplicate for glucose (YSI 2300, Yellow Springs Instru-
ments, Yellow Springs, Ohio) with the remainder stored
at −80
◦C. The frozen samples were analyzed in duplicate
for insulin using an endocrine assay (LINCOplex kit, St.
Charles, Mo), and measured by Luminex100 (Austin, Tex)
instrumentation. Once the samples were analyzed, the
highest value attained over the 120minutes was determined
tobethepeakvalue,withthediﬀerencebetweenbaselineand
peakdetermined tomeasurethechangefromfasting topeak.
Glucose and insulin areas under the curve (iAUC) were
determined using the trapezoid method (GraphPad Prism
v 5.02, La Jolla, Calif). This approach was adapted from a
previous RS feeding study [18]. Fasting insulin and glucose
values were also used to calculate the homeostasis model
assessment (HOMA) [23].
2.7. Diet and Physical Activity Records. A diet record was
completed by the volunteers prior the ﬁrst test of the study.
Volunteers were instructed on how to record their intakes.
They were requested to then eat the same foods from that
diet recorded the day before the second and third trials. This
procedure was used previously [24]. Also, volunteers were
requested to record their physical activity for the day before
testing and perform that same activity (or inactivity) the day
prior to the subsequent tests.
3.DataAnalysis
Sample size estimation was calculated using PASS software
(NCSS 2007 and PASS 2005, Kaysville, Utah). Based on
results from previously published data using RS2 [6], six
volunteers were determined necessary (power > 0.80, and
P<. 05) to detect signiﬁcant diﬀerences in glucose and
insulin responses. A repeated measures analysis of variance
(SPSS version 11.5, Chicago, Ill) was used to determine
signiﬁcant main eﬀects with signiﬁcance set at P = .05.
Paired t-tests (SPSS version 11.5, Chicago, Ill) were used to
determine diﬀerences between and among trials for peak,
change from baseline to peak and iAUC values for glucose
and insulin. The comparisons of interest were primarily
between the two bars, with the glucose treatment providing
a standard point of reference.
4. Results
The three meals provided practically the same amount (50-
51g) of available carbohydrate (Table 2). Both nutrition bars
contained similar amounts of protein and were low in fat,
but the RS4XL bar contained four times the dietary ﬁber
(20g versus 5g) compared to the PWB. Approximately one-
ﬁfth of the total dietary ﬁber in the RS4XL bar was from
gumarabic(∼4.4g)withtheremainder(∼15.6g)beingfrom
RS4XL. The meals diﬀered in their calculated food-energy
contents (200–326kcal, Table 2) because their compositions
diﬀered and because their weights to deliver 50g of available
carbohydrates diﬀered.
The commercially available RS4XL used in this study
contains 0.4% phosphors, 10.6% moisture, 91.9% total
dietary ﬁber by AOAC-International Method 991.43, and
83.3% RS by a modiﬁed Englyst method [25]. At the time
of preparing the 80g bar of RS4XL, the amount of RS added
was ∼20g (dry solids) according to the formula in Table 1
and the composition of Fibersym RW, while the amount
of gum arabic added was 4.4g (dry solids). At the time of
analyzing the ﬁnished 80g bar, the bar contained 20g of total
dietary ﬁber (Table 2). Assuming no loss of gum arabic in
the preparation of the RS4XL bar, the 4.4g loss of dietary
ﬁber could be attributed to some damage to the RS, which
increased its digestibility. Assuming the ratio of RS to dietary
ﬁber remains constant at 0.9 in partially damaged RS4XL,
thenthe80gbarofRS4XL fedtothesubjectscontained ∼14g
RS,implying ∼70%wasmaintainedfollowingpreparationof
the bar.
The RS4 bar elicited decreased glucose and insulin
concentrations at several time points (Figure 1) during the
120minutes postprandial period as compared with GLU and
PWB.Also,consumptionoftheRS4barledtoanattenuation4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 1: Depiction the glucose (a) and insulin (b) responses over two hours following the consumption of each (Glu, PWB, and RS4)
treatment. Values represent each mean ± SE. A: signiﬁcant diﬀerence with PWB; B: signiﬁcant diﬀerence with RS4.
of peak glucose and insulin, and signiﬁcant diﬀerences from
baseline to peak and iAUC values glucose and insulin when
compared with GLU and PWB (Table 3). The PWB bar
attenuated the peak glucose and insulin responses and the
iAUC for glucose and insulin compared with GLU. The
percent increase from baseline to peak was not diﬀerent (P =
.068) from GLU for glucose, while it was for insulin.
5. Discussion
These data, for the ﬁrst time, indicate that eating RS4XL
from wheat in place of standard wheat starch signiﬁcantly
decreased postprandial insulin and glucose responses. These
results are in line with others investigating the insulin and/or
glucose lowering eﬀects when RS (typically RS2) is added
to foods or incorporated in the diet [6, 16, 18, 26, 27],
while a few reported no eﬀect of RS2 or RS3 on glycemia
[7, 9]. Results from several other clinical trials reported
RS decreased the glycemic response, but those studies had
volunteers sprinkle RS onto the food instead of it being
an ingredient in the food, mixed only with water, ate large
(up to 388g) portion sizes, failed to control for available
carbohydrate, and/or the food eaten contained diﬀerent
ingredients with varying amounts of available carbohydrate
[6, 16, 18, 26, 27].
One of the more surprising outcomes was that RS4XL sig-
niﬁcantly attenuated the glycemic and insulinemic responses
even when high glycemic ingredients were eaten. This
observation is critical for consumers and food scientists
when looking for or creating foods to control blood glucose
levels in that they may not need to avoid foods containing
corn syrup or sugar for the purpose of regulating their
blood glucose levels. That is, these data clearly indicate that
even though two foods contain identical concentrations of
glycemic ingredients, the presence of RS4XL may signiﬁcantly
lower glucose and insulin responses. In the case of the bars
thatweretested,thevolunteersactuallyconsumedmorecorn
syrupandbrownsugarintheRS4XL barsincetheyconsumed
15gmoreofthatbarthanthePWBbar.Yet,theglycemicand
insulinemic responses for the RS4XL bar were signiﬁcantly
attenuated compared with the PWB bar that was matched
for available carbohydrate yet contained less (by weight)
sugar and corn syrup (Table 3). This does not imply that
eating sugar and corn syrup is healthy, but that foods high
in RS4XL attenuate glycemia and insulinemia compared with
those with standard whole wheat starch when sugarand corn
syrup are present and account for ∼30% of the energy. This
is of interest as sugar and corn syrup have been the target
of criticism for potentially contributing to the obesity and
diabetes epidemics [28–30].
The observed attenuation of the glucose and insulin
responses might be a result of high concentrations of DF
and/or RS in the RS4XL bar. In separate in vitro analyses for
DF and RS, this version of cross-linked RS4 has been shown
to contain 91.9% dietary ﬁber and 83% resistant starch [25].
Relative to clinical trials that used RS2, Le Leu et al. [31]
recently reported that several varieties of RS2 only contain
18–60%dietaryﬁberand46–53%RS.Thus,thiscross-linked
form of RS4 likely elicited the signiﬁcant diﬀerence due to a
relatively high content of ﬁber and RS.
This study is not without limitations. While we did
observe a signiﬁcant attenuation in glucose and insulin
responses when RS4XL was incorporated into the bar, it is
not possible to know whether the same eﬀects would occur
in individuals with insulin resistance or other metabolic
conditions. It could be suggested that the current dose used
for the RS4XL bar (80g) might be greater than one would
choose to consume at one sitting. A more realistic approach
might be to base the doses on average serving sizes, but that
would only oﬀer 15–20g of available carbohydrate in the
RS4XL bar. That said a previous study [26]h a dv o l u n t e e r s
consume treatment foods that were nearly ﬁve-fold greater.
Likewise, we were trying to match the amount of available
carbohydrate at 50g, which is recommended for glycemic
index testing [32]. Another potential confounding issue,
especially when comparing the bars with the solution, is the
diﬀerence in gastric emptying [33]. Also, the total energyJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
Table 3: Values for the incremental areas under the curves of glucose and insulin concentrations during each trial00. Mean ± SE; diﬀerent
letters within a row indicates signiﬁcant diﬀerence (P < .05).
GLUC PWB RS4XL
Glucose
iAUC (mmol/L • 2 hr) 140 ±31A 84 ±17B 28 ±11C
Peak (mmol/L) 7.30 ±0.5A 6.33 ±0.3B 5.40 ±0.2C
Increase (%) 60.5 ±10A 42.7 ±6A 20.4 ±3B
iAUC (pM • 2 hr) 17,575 ±2,236A 8,758 ±1,132B 3,659 ±974C
Peak (pM) 344 ± 36.7A 211.5 ±20.1B 162.3 ±22.6C
Increase (%) 335 ± 53.2A 243.0 ±49.3B 126.3 ±45.8C
contained within the RS4XL bar did not take into account
the energy provided via fermentation of the RSXL into short
chainfattyacids.Lastly,wecannotdeterminethemechanism
for the eﬀect observed. It is reasonable to conclude that
the RS4XL caused the eﬀects, as it was the only ingredient
diﬀerence, but it is not possible to determine how much of
the change was attributable to the dietary ﬁber or the RS that
is contained within RS4XL.
In conclusion, this is the ﬁrst published randomized
clinical trial to investigate the glucose and insulin lowering
potential of RS4XL. Additionally, this is one of a few clinical
studies where the treatments were matched for available
carbohydrateandtheRSwassubstituteddirectlyforstandard
starch in the tested food, while all other ingredients were
identical. This ingredient and nutrient control minimizes
confounding factors that are present when treatments are
matched instead for total carbohydrate [18] or when dif-
ferent ingredients are used in clinical trials [16]. While it is
unknown what component (dietary ﬁber or resistant starch)
of RS4XL lowered glucose and insulin, it is clear that RS4XL
was responsible for the observed diﬀerences between bars.
Abbreviations
DF: Dietary ﬁber
GLU: Glucose control solution
iAUC: Incremental area under the curve
HOMA: Homeostasis Model Assessment of insulin
sensitivity
PWB: Control bar made with puﬀed wheat
RS: Resistant starch
RS4XL: Treatment bar made with cross-linked resistant
starch type 4.
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